NCT07756918 Effects of Extracorporeal Shockwave Therapy Versus Dry Needling on Jumpers Knee
| NCT ID | NCT07756918 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-10-15 |
| Primary Completion | 2026-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-10-15 with a primary completion date of 2026-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is randomized and single-blinded. Ethical approval is taken from ethical committee of Riphah International University, Lahore. Participants who meet the inclusion criteria will be enrolled and allocated in group A \& B through sealed envelope method by Non-probability Convenient random sampling technique. Subjects in Group A will receive Shock wave therapy. Group B will receive Dry needing.
Eligibility Criteria
Inclusion Criteria: * Participants of either gender between the age of 18-35 years with a confirmed diagnosis of jumper's knee for more than 1 month. * Confirmed diagnosis of jumper's knee for more than 1 month. * Pain NPRS (Numeric Pain Rating Scale) score greater than 4 at the first evaluation. Exclusion Criteria: * Surgery around the knee joint within the last 6 months. * Chronic knee joint disease. * Knee pain management with corticosteroid injections in the last 3 months. * Trauma history * Systemic illness
Contact & Investigator
Waqas Qadir, DPT
PRINCIPAL INVESTIGATOR
Study Principal Investigator
Frequently Asked Questions
Who can join the NCT07756918 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07756918 currently recruiting?
Yes, NCT07756918 is actively recruiting participants. Contact the research team at amna.shahid@riphah.edu.pk for enrollment information.
Where is the NCT07756918 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07756918 clinical trial?
NCT07756918 is sponsored by Riphah International University. The principal investigator is Waqas Qadir, DPT at Study Principal Investigator. The trial plans to enroll 48 participants.